Entasis Therapeutics, created in 2015 (United States), from 2214 competing brands. Entasis Therapeutics is owned by Entasis Therapeutics Holdings Inc., listed on the stock exchange of New York Entasis Therapeutics is part of the Biotechnology activity sector.
Buy Entasis Therapeutics Holdings Inc. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
